OS Therapies (OSTX) announced that it has entered into securities purchase agreements with investors to sell 1.5M units at a price of $4.00 per unit, with each unit consisting of one share of Series A Senior Convertible Preferred Stock initially convertible into one share of common stock and one warrant to purchase one share of common stock, expected to yield gross proceeds to the company of $6M, before deducting offering-related expenses. The conversion price of the Preferred Stock into shares of common stock is $4.00 and the exercise price of the warrants is $4.40 per share. The private placement is expected to close on or about December 27, subject to the satisfaction of customary closing conditions. Brookline Capital Markets, a division of Arcadia Securities, served as placement agent and Ceros Financial Services was engaged as a selected dealer to the placement agent.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on OSTX:
